MedPath

Enhanced Diagnostics for Early Detection of Atrial Fibrillation

Completed
Conditions
Atrial Fibrillation
Registration Number
NCT02270112
Lead Sponsor
University Hospital, Basel, Switzerland
Brief Summary

Paroxysmal atrial fibrillation can only be diagnosed during episodes when the arrhythmia is present.

The investigators hypothesize that the activation of the atrial myocardium resulting in the p-wave of the ecg should display abnormalities in diseased atria which are vulnerable for AF.

Detailed Description

In the first part of this trial different diagnostic techniques to detect arrythmogenic substrates of atrial fibrillation will be tested. If suitable parameters can be identified, a follow up trial to identify patients at risk for AF will be conducted before a stroke happens.

Parameters tested are

1. Electrophysiological differences between patients with paroxysmal AF and no history of AF

2. "Vascular Stiffness" detected by an iPhone app

All patients will undergo a cardiogoniometrie and a pulse wave analysis with an iPhone. Each exam takes 5 minutes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
287
Inclusion Criteria
  • paroxysmal atrial fibrillation in sinus rhythm at presentation
Exclusion Criteria
  • acute cerebral trauma
  • antiarrhythmic medication

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Beat to beat variation of the electrical activation vector of the atriumOnce during the exam (baseline) - No further follow up planned

Test if the beat to beat Variation of the electrical activation of the atrium differentiates between the group of patients with paroxysmal AF and no AF in history.

Secondary Outcome Measures
NameTimeMethod
Averaged slope of pressure-curveOnce during exam (5min, baseline) - No further follow up planned

Test if the steepness of the slope of the pressure curve recorded with the iPhone correlates with cardiovascular risk factors.

Heart rate variabilityOnce during exam (5min, baseline) - No further follow up planned

Test if heart rate variability recorded with the iPhone differs between the two Groups.

Trial Locations

Locations (1)

University Hospital Basel

🇨🇭

Basel, BS, Switzerland

University Hospital Basel
🇨🇭Basel, BS, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.